International scheduling Australia's Therapeutic Goods Administration (interim decision, April 2024) and New Zealand's Medsafe (Medicines Classification Committee, June 2025) have moved to schedule BPC-157 as a prescription-only medicine, despite its unavailability through legitimate prescription
Recalls & Warnings November 09, 2023 Zazzee Naturals Warned for MSM Eye Drop Claims On October 30, 2023, the FDA issued a Warning Letter to Dexterity Health, LLC DBA Zazzee Naturals following review of the companys Amazon storefront, which found statements about the companys Liquid MSM Drops to be drug claims
Summary: Why AOD-9604 Is Gaining Popularity AOD-9604 offers a science-backed, targeted approach to fat reduction with added benefits in metabolic health and joint supportall with a low risk of side effects
If BPC-157 genuinely promotes VEGF expression in those tissues, it addresses one of the core bottlenecks in musculoskeletal recovery
Its conceptual foundation came from the observation that gastric mucosa survives in an environment exposed to acid, enzymes, and mechanical stress